Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-24

Clinical Trial Update: Anterior and Posterior Segment Vascular Changes Following Laser and Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Diabetic Retinopathy

View source ↗

Summary

This clinical trial update reports on anterior and posterior segment vascular changes observed after laser therapy in combination with anti-VEGF treatment for d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)
  • EYLEA (Aflibercept)
  • Lucentis (ranibizumab)

Snippet

Sponsor: University of Toronto | Conditions: Diabetic Macular Edema | Status: UNKNOWN